COSOLA, CARMELA
 Distribuzione geografica
Continente #
NA - Nord America 909
EU - Europa 145
AS - Asia 70
Totale 1.124
Nazione #
US - Stati Uniti d'America 905
SE - Svezia 66
CN - Cina 61
IT - Italia 34
DE - Germania 10
GB - Regno Unito 10
FI - Finlandia 7
VN - Vietnam 7
BE - Belgio 6
CA - Canada 4
FR - Francia 4
NL - Olanda 3
IE - Irlanda 2
UA - Ucraina 2
IN - India 1
LA - Repubblica Popolare Democratica del Laos 1
RU - Federazione Russa 1
Totale 1.124
Città #
Fairfield 159
Woodbridge 111
Ashburn 107
Chandler 86
Nyköping 57
Cambridge 55
Seattle 53
Ann Arbor 48
Wilmington 47
Houston 45
Beijing 25
Lawrence 16
Roxbury 15
Nanjing 12
New York 11
Des Moines 8
Inglewood 8
San Diego 8
Dong Ket 7
Brooklyn 6
Brussels 6
Nanchang 5
Washington 5
Bari 4
Biassono 4
Changsha 4
Helsinki 4
Jacksonville 4
Princeton 4
Falls Church 3
Jiaxing 3
Paris 3
Redwood City 3
Syracuse 3
Toronto 3
Acton 2
Boardman 2
Dublin 2
Grumo Appula 2
Jinan 2
Leawood 2
Mola Di Bari 2
Nagold 2
Ningbo 2
Shenyang 2
Tianjin 2
Dearborn 1
Decatur 1
Florence 1
Groningen 1
Guangzhou 1
Hangzhou 1
Hefei 1
London 1
Marseille 1
Monmouth Junction 1
Naples 1
Norwalk 1
Pune 1
Santa Clara 1
Simi Valley 1
Taizhou 1
Tappahannock 1
Totale 981
Nome #
Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals. 118
null 108
Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake 97
null 89
Nutritional treatment of advanced CKD: twenty consensus statements 77
Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study) 73
null 68
null 59
null 57
Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-cresol Sulfate in Hemodialysis Patients: Results from an in Vitro Study and an in Vivo Pilot Trial (xuanro4-Nature 3.2) 55
null 52
Activation of NADPH oxidase and coagulation cascade in renal ischemia-reperfusion (I/R) 48
Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study) 47
AKI and stem cells 46
[Nutritional diet therapy in the management of the patient with Chronic Kidney Disease in advanced phase to delay the beginning and reduce the frequency of dialysis. An option also in the pre-emptive transplant program] 33
Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease 28
An innovative synbiotic formulation decreases free serum indoxyl sulfate, small intestine permeability and ameliorates gastrointestinal symptoms in a randomized pilot trial in stage IIIb-IV CKD patients 28
Microbiota issue in CKD: how promising are gut-targeted approaches? 25
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease 24
MO014A LOW-SODIUM BREAD IMPROVES THE ADHERENCE TO A LOW-SODIUM DIET IN HYPERTENSIVE SUBJECTS 20
Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease 16
Nutrients, Nutraceuticals, and Xenobiotics Affecting Renal Health 14
Obesity-Related Chronic Kidney Disease: Principal Mechanisms and New Approaches in Nutritional Management 10
Effects of low-sodium bread on dietary compliance and fecal cultivable bacteria in a randomized controlled pilot trial in hypertensive subjects 1
Totale 1.193
Categoria #
all - tutte 4.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201994 0 0 0 0 0 0 0 0 0 18 36 40
2019/2020337 33 10 8 34 43 24 28 40 44 39 20 14
2020/2021198 7 19 9 13 41 16 8 20 13 21 14 17
2021/2022140 11 3 0 5 5 16 5 5 20 12 20 38
2022/2023225 23 45 17 12 19 32 3 32 31 0 5 6
2023/2024115 8 12 7 11 19 40 1 13 4 0 0 0
Totale 1.193